{"id":"NCT01081132","sponsor":"Shire","briefTitle":"Dose-optimization in Adolescents Aged 13-17 Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD) Using Extended-release Guanfacine HCl","officialTitle":"A Phase 3, Double-blind, Randomized, Multi-center, Placebo Controlled, Dose-optimization Study Evaluating the Safety, Efficacy, and Tolerability of Once Daily Dosing With Extended-release Guanfacine Hydrochloride in Adolescents Aged 13-17 Years Diagnosed With Attention-deficit/Hyperactivity Disorder (ADHD)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-09-19","primaryCompletion":"2013-05-16","completion":"2013-05-16","firstPosted":"2010-03-05","resultsPosted":"2014-05-23","lastUpdate":"2021-06-28"},"enrollment":314,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Attention-Deficit/Hyperactivity Disorder"],"interventions":[{"type":"DRUG","name":"Extended-release Guanfacine Hydrochloride","otherNames":["Intuniv"]},{"type":"OTHER","name":"Placebo","otherNames":[]}],"arms":[{"label":"Extended-release Guanfacine HCl","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"To assess the efficacy of optimized Extended-release Guanfacine Hydrochloride compared with placebo in the treatment of adolescents aged 13-17 years with a diagnosis of ADHD as measured by the ADHD-RS-IV","primaryOutcome":{"measure":"Change From Baseline in Attention Deficit Hyperactivity Disorder Rating Scale-fourth Edition (ADHD-RS-IV) Total Score at Week 13","timeFrame":"Baseline through week 13","effectByArm":[{"arm":"PLACEBO","deltaMin":-18.527,"sd":1.0841},{"arm":"SPD503","deltaMin":-24.552,"sd":1.0625}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"13 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":54,"countries":["United States"]},"refs":{"pmids":["26506582"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":155},"commonTop":["Somnolence","Headache","Fatigue","Decreased appetite","Dizziness"]}}